Ottimo Pharma
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $142M
Investors
- 9
About Ottimo Pharma
Founded in 2020, and based in the UK, Ottimo Pharma is dedicated to the creation of advanced cancer therapeutics. The founder has a background in the biotech industry, although specific prior ventures are not disclosed. Medicxi and Jonny Finlay co-founded the firm. David Epstein is leading the firm as CEO as of 2024. Ottimo Pharma is engaged in the development of bifunctional medicines that target the PD1 and VEGFR2 pathways, essential in cancer treatment. Their therapeutics are designed to offer a wide therapeutic index for treatment with reduced toxicity, aimed at extending the lives of cancer patients. The primary beneficiaries of these products include oncologists and healthcare institutions, with ongoing evaluations in clinical settings across North America, Europe, and parts of Asia. Ottimo Pharma's revenue generation model is built on partnerships with healthcare providers and research institutions to support the development and commercialization of its bifunctional medicines.00 mn to advance its lead molecule, Jankistomig, and develop additional bifunctional assets. The company is targeting the expansion of its product offerings into new markets, specifically aiming to reach more healthcare providers in North America, Europe, and parts of Asia by the end of 2025.
Who invested in Ottimo Pharma
9 investors across 1 round
See all investors in Ottimo Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 18, 2024
Amount
$142M
Investors
Questions about Ottimo Pharma
Who invested in Ottimo Pharma?
Ottimo Pharma has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ottimo Pharma raised?
Ottimo Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ottimo Pharma last raise money?
Ottimo Pharma's most recent round on record is a Series A, in Dec 2024.
What does Ottimo Pharma do?
Founded in 2020, and based in the UK, Ottimo Pharma is dedicated to the creation of advanced cancer therapeutics.
Where is Ottimo Pharma headquartered?
Ottimo Pharma is headquartered in Kent, UK.
Which VCs invest in companies like Ottimo Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Ottimo Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ottimo Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.